Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

ClinicalTrials.gov ID: NCT00133198

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00133198. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 1:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Trial Comparing Fixed Doses of 0.25 mg, 0.50 mg and 0.75 mg Pramipexole (Mirapex®) Administered Orally to Investigate the Safety and Efficacy in Patients With Idiopathic Restless Legs Syndrome for 12 Weeks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 12 week clinical trial was conducted in the United States in order to compare pramipexole (Mirapex®) versus placebo for the ability to reduce the symptoms of restless legs syndrome in adult subjects.

Study identification

NCT ID
NCT00133198
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
345 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2004 (Type not available)
Primary completion
Feb 2005 (Actual)
Completion
Feb 2005 (Type not available)
Last update posted
Nov 8, 2013

2004 – 2005

United States locations

U.S. sites
44
U.S. states
24
U.S. cities
42
Facility City State ZIP Site status
Pivotal Research Centers Peoria Arizona 85381 —
Mayo Clinic - Scottsdale Scottsdale Arizona 85259 —
Boehringer Ingelheim Investigational Site Fountain Valley California 92708 —
HealthQuest Clinical Trials Research San Diego California 92123 —
Stanford Sleep Clinic Stanford California 94305-5730 —
Adult CF Center Denver Colorado 80206 —
University of Colorado Health Sciences Center Denver Colorado 80262 —
CNI Movement Disorders Center Englewood Colorado 80113 —
George Washington University Medical Faculty Associates Washington D.C. District of Columbia 20037 —
PAB Clinical Research Brandon Florida 33511 —
Broward Research Group Pembroke Pines Florida 33026-1956 —
Clinical Research Group of St Petersburg St. Petersburg Florida 33707 —
Cleveland Clinic Florida- Department of Neurology Weston Florida 33331 —
5671 Peachtree Dunwoody Road Atlanta Georgia 30342 —
Atlanta Pulmonary Group, LLC Atlanta Georgia 30342 —
Movement Disorders Clinic Augusta Georgia 30912 —
Sleepmed, Inc Macon Georgia 31201 —
University of Iowa Health Care Iowa City Iowa 52242-1053 —
Mid America NeuroScience Institute Lenexa Kansas 66214 —
Boehringer Ingelheim Investigational Site Baton Rouge Louisiana 70808 —
Center for Sleep and Wake Disorders Chevy Chase Maryland 20815 —
170 Thomas Johnson Dr, Suite 100 Frederick Maryland 21702 —
Sleep Health Centers Newton Center Massachusetts 02459 —
Henry Ford Hospital - Sleep Disorders and Research Center Detroit Michigan 48202 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
Sleep Disorders Center Jackson Mississippi 39216 —
Sleep Medicine Center St Louis Missouri 63108 —
Lovelace Scientific Resources Albuquerque New Mexico 87108 —
Winthrop Sleep Disorders Center Mineola New York 11501 —
932 Morreene Road #264 Durham North Carolina 27705 —
Raleigh Neurology Associates Raleigh North Carolina 27607 —
Wilmington Health Associates Wilmington North Carolina 28401 —
Attn: Dr. David Mayleben Cincinnati Ohio 45219 —
Metrohealth Medical Center Cleveland Ohio 44109 —
Ohio Sleep Medicine Institute Dublin Ohio 43017 —
Attn: Controller/Grants & Contracts Accounting Oklahoma City Oklahoma 73190-3046 —
Center For Sleep Medicine Lafayette Hill Pennsylvania 19444 —
The Arthritis Group Philadelphia Pennsylvania 19152 —
Boehringer Ingelheim Investigational Site Columbia South Carolina 29201 —
Baylor College of Medicine Houston Texas 77030 —
Sleep Associates Plano Texas 75093 —
1500 N. Bearegard St, #300 Alexandria Virginia 22311 —
Lynchburg Pulmonary Associates, Inc. Lynchburg Virginia 24501 —
Eastern Virginia Medical School Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00133198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2013 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.